Published in Lab Business Week, January 1st, 2006
Combining biotechnology and nanotechnology, Adnavance is developing product applications that use the electrical conductivity properties of both DNA and novel metallic forms of DNA (M-DNA), for the healthcare and nanotechnology industries.
Adnavance has also secured substantial non-dilutive funding from The National Research Council's Industrial Research Assistance Program (NRC-IRAP) and from The Natural Sciences and Engineering Research Council of Canada (NSERC), to support its research and development programs.
"This is a significant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.